Background Systemic corticosteroid therapy is central to the management of acute asthma.
The use of inhaled corticosteroids (ICS) may also be beneficial in this setting. Objectives To …

Background Asthma, one of the most common chronic respiratory diseases, affects about 3
million Canadians. The objective of this study is to provide a comprehensive evaluation of …

For years, standard asthma treatment has included short acting beta agonists (SABA),
including as monotherapy in patients with mild asthma symptoms. In the Global Initiative for …

Background Inhaled short‐acting anticholinergics (SAAC) and short‐acting beta₂‐agonists
(SABA) are effective therapies for adult patients with acute asthma who present to the …

Background Patients with acute asthma treated in the emergency department (ED) are
frequently treated with inhaled beta 2‐agonists and systemic corticosteroids after discharge …

Abstract Background The French Emergency Medicine Society, the French Intensive Care
Society and the Pediatric Intensive Care and Emergency Medicine French-Speaking Group …

Asthma is a condition of significant public health concern associated with morbidity, mortality
and healthcare utilisation. This study identifies key determinants of length of stay (LOS) …

Background Inhaled beta2‐agonist therapy is central to the management of acute asthma.
For rapid bronchodilation in severe cases, penetration of inhaled drug to the affected small …

Objectives: A variable proportion of patients presenting to the emergency department (ED)
with acute asthma require admission to hospital. Previous studies have identified select …

Objectives Patients with asthma commonly present to emergency departments (ED) with
exacerbations. Asthma guidelines recommend close follow‐up with a primary care provider …